Evaluating safety and efficacy of combining AB-729, VTP-300, nucleos(t)ide analogues and nivolumab (Opdivo®...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RAPT Therapeutics (RAPT – Research Report...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cassava Sciences (SAVA – Research Report), Apellis...
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Vaccitech Plc (VACC - Research Report), with a price target of...
OXFORD, United Kingdom, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
OXFORD, United Kingdom, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced its...
OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Vaccitech Plc (VACC – Research Report) today and set a price target of $22.00. The...
VTP-300 as a monotherapy and in combination with a single administration of low-dose nivolumab was...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adicet Bio (ACET – Research Report), Ayala...
OXFORD, United Kingdom, June 06, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.